Cost-effectiveness of HIV post-exposure prophylaxis in France

To assess the cost-effectiveness of HIV post-exposure prophylaxis (PEP) in France. We used a decision tree to evaluate, from a society's perspective, the cost of PEP per quality-adjusted life-year (QALY) saved. We used 1999-2003 PEP surveillance data and literature-derived data on per event tra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2006-08, Vol.20 (13), p.1753-1761
Hauptverfasser:	HERIDA, Magid, LARSEN, Christine, LOT, Florence, LAPORTE, Anne, DESENCLOS, Jean-Claude, HAMERS, Francoise F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiretroviral Therapy, Highly Active - economics Biological and medical sciences Cost-Benefit Analysis Female France - epidemiology HIV Infections - economics HIV Infections - epidemiology HIV Infections - prevention & control Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Life Expectancy Male Medical sciences Middle Aged Occupational Exposure - adverse effects Quality-Adjusted Life Years Substance Abuse, Intravenous - epidemiology Unsafe Sex Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!